COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,009 Articles (22,627 medRxiv, 8,382 bioRxiv)

Most recent first Previous |  Page 152: Articles 1511-1520  | Next

Spatio-temporal transmissibility and dispersion of SARS-CoV-2 variants and sub-variants of concern in England
Swallow, B., Grier, J., Panovska-Griffiths, J.
10.1101/2024.08.14.24311985 — Posted: 2024-08-17
Common and rare variant analyses reveal novel genetic factors underlying Idiopathic Pulmonary Fibrosis and shared aetiology with COVID-19
Kousathanas, A., Odhams, C. A., Cook, J., Hu, Y., Klee, S., Erzurumluoglu, A. M., Ramirez, F., Mayr, C., Schafer, D., Beck, L., Christ, I., Lee, T., Tarr, J. C., Fesik, S. W., Boehringer Ingelheim - Global Computational Biology and Digital Sciences, , Duboff, J., Wirtz-Peitz, F., Moutsianas, L., Brown, M. A., Kriegl, J., Okafo, G., Jensen, J. N., Thomas, M. J., Ding, Z.
10.1101/2024.08.16.24312138 — Posted: 2024-08-17
Healthcare workers mental health during the COVID-19 pandemic: A qualitative analysis of a text message-based NHS workforce support line
Gould, L. J., Lawrence, E., Powell, R., Angwin, E.
10.1101/2024.08.16.24311723 — Posted: 2024-08-17
Obstructive Sleep Apnea is a Risk Factor for Incident COVID-19 Infection
Quan, S., Weaver, M. D., Czeisler, M. E., Barger, L. K., Booker, L. A., Howard, M. E., Jackson, M. L., McDonald, C. F., Ridgers, A., Robbins, R., Varma, P., Rajaratnam, S. M., Czeisler, C. A.
10.1101/2024.08.15.24312067 — Posted: 2024-08-16
SARS-CoV-2 and Mycobacterium tuberculosis co-infection in vitro
Lucena, T. M. C. d., Miranda, D. E. O., Arcoverde, J. V. B., Cavalcanti, M. S. B., Rabello, M. C. d. S., Silva, J. d. A.
10.1101/2024.08.14.607914 — Posted: 2024-08-15
AAB-seq: An antigen-specific and affinity-readable high-throughput BCR sequencing method
Hu, M., Lian, Q., Cui, X., Dong, X., Xin, H., Shi, W.
10.1101/2024.08.13.607736 — Posted: 2024-08-15
Identification of biomarkers for COVID-19 associated secondary hemophagocytic lymphohistiocytosis
Canny, S. P., Stanaway, I. B., Holton, S. E., Mitchem, M. A., O'Rourke, A., Pribitzer, S., Baxter, S. K., Wurfel, M. M., Malhotra, U., Buckner, J. H., Bhatraju, P. K., Morrell, E. D., Speake, C., Mikacenic, C., Hamerman, J.
10.1101/2024.08.13.607855 — Posted: 2024-08-15
Profiling serum immunodominance following SARS-CoV-2 primary and breakthrough infection reveals distinct variant-specific epitope usage and immune imprinting.
Seow, J., Jefferson, G. C. E., Keegan, M., Yau, Y., Snell, L. B., Doores, K. J.
10.1101/2024.08.14.607882 — Posted: 2024-08-15
SARS-CoV-2 genomic surveillance from community-distributed rapid antigen tests
Emmen, I. E., Vuyk, W. C., Lail, A. J., Wolf, S., O'Connor, E. J., Dalvie, R., Bhasin, M., Virdi, A., White, C., Hassan, N. R., Richardson, A., VanSleet, G., Weiler, A. M., Rounds-Dunn, S., Van Horn, K., Gartler, M., Jorgenson, J., Spelman, M., Ottosen, S., Minor, N. R., Wilson, N., Friedrich, T., O'Connor, D.
10.1101/2024.08.12.24311680 — Posted: 2024-08-14
Severe acute respiratory syndrome (SARS) mathematical models and disease parameters: a systematic review and meta-analysis
Morgenstern, C., Rawson, T., Routledge, I., Kont, M., Imai-Eaton, N., Skarp, J. E., Doohan, P., McCain, K., Johnson, R., Unwin, H. J. T., Naidoo, T., Dee, D. P., Parchani, K., Cracknell Daniels, B. N., Vicco, A., Drake, K. O., Christen, P., Sheppard, R. J., Leuba, S. I., Hicks, J. T., McCabe, R., Nash, R. K., Santoni, C. N., Pathogen Epidemiology Review Group, , Cuomo-Dannenburg, G., van Elsland, S., Bhatia, S., Cori, A.
10.1101/2024.08.13.24311934 — Posted: 2024-08-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).